MedAvante, Inc.

NJBIZ STAFF//November 25, 2013//

Listen to this article

The hurdles are falling for drug companies relying on subjective measurements of whether their products make a difference, especially in the area of central nervous system health. They can thank MedAvante, which has been working since 2002 to make those measurements more precise and objective. It has found a steadily growing base of customers in the pharmaceutical, biotechnology and medical device industries in North America, Europe and Asia. The company is looking to expand in other fields where subjective assessments play a role.